An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Appro...
An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease
About this item
Full title
An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease
Author / Creator
Publisher
US: Oxford University Press
Journal title
Inflammatory bowel diseases, 2024-12, Vol.30 (12), p.2523-2525
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
More information
Alternative Titles
Full title
An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3114153531
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3114153531
Other Identifiers
ISSN
1078-0998,1536-4844
E-ISSN
1536-4844
DOI
10.1093/ibd/izae226
